Table 2. The main clinicopathological characteristics of the 107 esophageal cancer patients.
| Parameter | N = 107(%) |
|---|---|
| Gender | |
| Male | 92 (86.0%) |
| Female | 15 (14.0%) |
| Age | |
| ≤65 | 75 (70.1%) |
| >65 | 32 (29.9%) |
| Grade | |
| G1 | 14 (13.1%) |
| G2 | 60 (56.1%) |
| G3 | 33 (30.8%) |
| Stage | |
| I | 16 (15.0%) |
| II | 56 (52.4%) |
| III | 30 (28.0%) |
| IV | 5 (4.6%) |
| T | |
| T1 | 16 (15.0%) |
| T2 | 30 (28.0%) |
| T3 | 58 (54.2%) |
| T4 | 3 (2.8%) |
| N | |
| N0 | 54 (50.5%) |
| N1 | 42 (39.2%) |
| N2 | 6 (5.6%) |
| N3 | 5 (4.7%) |
| M | |
| M0 | 102 (95.3%) |
| M1 | 5 (4.7%) |